AMRI (NASDAQ: AMRI) announced the extension of a k with a major pharmaceutical company designed to accelerate their chemistry and ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE